WHO-HAEM4R included large B-cell lymphoma with IRF4 rearrangement, a de novo B-cell lymphoma with a follicular and/or diffuse pattern, strong expression of IRF4/MUM1 and a favorable prognosis, as a provisional entity. This evidence concerns the gene IRF4 and B-cell non-Hodgkin lymphoma.